Execution of a medical specialist:
Shingles is a half-sided, very painful skin rash that often spreads like a belt when the upper part of the body is affected.
Shingles (herpes zoster) is caused by an infection with the chickenpox virus (varicella zoster virus) and should not be confused with herpes simplex, even if the varicella zoster virus itself is subsumed under herpes viruses.
In most cases, chickenpox (varicella), a systemic infectious disease that most people had already experienced as children before the chickenpox vaccination was introduced, occurs first after transmission of the varicella-zoster virus.
Even after overcoming this systemic viral infection, the Varicella zoster virus remains inactive in the human body within virus reservoirs, which are typically localized in the cranial nerves and in the nerve roots of the spinal cord (spinal and cranial nerve ganglia).
If the human organism is exposed to particular stresses, for example increasing biological ageing or weakening of the immune system, Varicella zoster viruses are reactivated in their reservoirs and migrate along nerves to the outside of the skin. Shingles develops in the area supplied by the nerves to which the viruses had previously retreated.
This disease process is usually very, very painful.
Intense pain often occurs before the first blisters form.
Patients with shingles can transmit the varicella zoster virus via smear infection, making the disease contagious in the early stages.
In addition to typical half-sided skin manifestations in the area of the trunk, varicella zoster inflammation of the cranial nerves is considered a serious complication, as it leads to facial paralysis if the facial nerve is affected and to possible permanent visual impairment if the upper branch of the trigeminal nerve is affected.
In very severe cases, meningitis or encephalitis or meningoencephalitis caused by Varicella zoster viruses may occur.
Clinical manifestations of the varicella zoster virus pose differential diagnostic problems for physicians diagnosing the disease when a viral infection is present.
spinal nerves are affected, but the typical blisters do not form.
Due to the sometimes very intense pain sensation, misdiagnoses such as a suspected heart attack can occur.
Qualified treatment of a varicella zoster infection involves consistent treatment with antivirals, with pharmaceuticals such as acyclovir, famciclovir, valaciclovir or brivudine, which are also administered parenterally, intravenously, to achieve greater therapeutic efficacy.
Practitioners who recruit alternative treatment approaches and, above all, affected patients themselves are increasingly opting to take colloidal nano-silver solution in such acute and emergency medical situations because they assume that colloidal silver has a broad spectrum of efficacy against viruses.
Immunocompromised patients in particular opt for the implementation of proper “silver cures”.
For the possible therapeutic effectiveness of this procedure, it is expressly pointed out at this point: Colloidal nano-silver solution is composed of water, distilled water, with the addition of silver, ideally colloidal silver in nano-particle size.
In order to be able, at least in theory, to arrive at the assumption of a “systemically” effective medicine based on silver that is effective against inflammatory processes in the human body, there has so far been a complete lack of scientific foundations and scientific evidence of the therapeutic effectiveness of silver in the human organism.
There are scientific research results on the antibacterial and antiviral properties of silver nanoparticles that have been determined experimentally under laboratory conditions. However, the potential use of silver particles for the treatment of respiratory tract infections, for example, and in principle for the treatment of systemic viral infections in the human organism has never been investigated.
Therefore, according to the current state of knowledge in medicine and science, the use of colloidal nano-silver in the case of an infection with varicella zoster can in no way be regarded as an alternative therapy concept to an urgently indicated application of antivirals, but at best as a subsidiary, auxiliary supportive procedure based on the hypothetical approach that metal complexes, thus also silver ions, could be able to penetrate tissue infected by viruses in the human organism and damage or destroy viral material there.
An interim result of an Israeli study postulates that the metals used to produce nanoparticles are interchangeable and that it is by no means only silver that can be used, but also other metals or metal oxides.
The study concludes that metal nanoparticle colloids (NpC) appear suitable for docking onto viruses under certain conditions.
However, there is explicitly no mention of a therapeutically usable efficacy of silver colloids, but it is put forward as a challenge to science to carry out corresponding experimental studies on the therapeutically usable efficacy of metal nanoparticle colloids in the future.
This means that, according to current scientific knowledge, there is no experimental evidence of the effectiveness of colloidal silver solution in the human organism.
Against this background, if affected patients as well as healthcare professionals decide to administer colloidal nano-silver solution to treat a zoster infection, they would be negligent if they were to forego the application of effective antivirals in the course of such a therapeutic approach.
Future experimental studies could possibly show that they were right to rely on a therapeutically implementable efficacy of colloidal silver solution against varicella-zoster infections.
Empirically determined data on any statistically representable healing results in connection with the application of colloidal silver solution and zoster neuralgia or results of experimental studies that could indicate such a specific therapeutic potential of colloidal nano-silver solution are not yet available.
Since neither of these conditions has been met to date, practitioners would be operating with a not unproblematic “therapeutic black box” if they indicated colloidal nano-silver solution for an infection with the varicella zoster virus. You would be using a product whose efficacy could perhaps one day be proven, but which, according to current knowledge, cannot be judged to be either beneficial or curative.
In this respect, colloidal silver in the treatment of herpes zoster is not yet classified as a remedy, let alone as a medicinal product.
Have you already discovered the fascinating reports on cold sores?
There are no scientifically proven findings on the effectiveness of such forms of treatment.
